GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (OTCPK:MEDXF) » Definitions » 5-Year Dividend Growth Rate

Medexus Pharmaceuticals (Medexus Pharmaceuticals) 5-Year Dividend Growth Rate : 0.00% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Medexus Pharmaceuticals 5-Year Dividend Growth Rate?

Medexus Pharmaceuticals's Dividends per Share for the three months ended in Dec. 2023 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Medexus Pharmaceuticals's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.00. As of today, Medexus Pharmaceuticals's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Medexus Pharmaceuticals's 5-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Medexus Pharmaceuticals's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medexus Pharmaceuticals's 5-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medexus Pharmaceuticals's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Medexus Pharmaceuticals's 5-Year Dividend Growth Rate falls into.



Medexus Pharmaceuticals 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Medexus Pharmaceuticals  (OTCPK:MEDXF) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Medexus Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ -0.028
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medexus Pharmaceuticals 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Medexus Pharmaceuticals (Medexus Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1
Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.

Medexus Pharmaceuticals (Medexus Pharmaceuticals) Headlines

From GuruFocus

Medexus Schedules Fourth Quarter and Fiscal Year 2022 Conference Call

By GuruFocusNews GuruFocusNews 06-24-2022

Medexus Announces New License Deal for Topical Terbinafine

By sperokesalga sperokesalga 03-22-2023

Treosulfan Pivotal Study Results Published

By GuruFocusNews GuruFocusNews 07-06-2022

Treosulfan Pivotal Study Results Published

By GuruFocusNews GuruFocusNews 06-26-2022

Medexus Welcomes Two New Board Members

By Stock market mentor Stock market mentor 02-06-2023

Medexus Schedules Fourth Quarter and Fiscal Year 2022 Conference Call

By GuruFocusNews GuruFocusNews 07-04-2022

Medexus Schedules Third Fiscal Quarter 2023 Conference Call

By Stock market mentor Stock market mentor 01-31-2023

Medexus Welcomes Two New Board Members

By GlobeNewswire GlobeNewswire 02-06-2023